Phil Skolnick insider trades: Opiant Pharmaceuticals (OPNT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Phil reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | OPNT | ↓ Sell | 480 | $20.26 | $10K | Direct | Jan 31, 2023 (4d) |
| Jan 9, 2023 | OPNT | ↓ Sell | 369 | $20.20 | $7K | Direct | Jan 9, 2023 (0d) |
| Jan 5, 2023 | OPNT | ↓ Sell | 1,421 | $20.20 | $29K | Direct | Jan 5, 2023 (0d) |
| Jul 14, 2022 | OPNT | ↓ Sell | 627 | $11.85 | $7K | Direct | Jul 15, 2022 (1d) |
| Jan 27, 2022 | OPNT | ↓ Sell | 1,518 | $26.19 | $40K | Direct | Jan 27, 2022 (0d) |
| Jan 10, 2022 | OPNT | ↓ Sell | 385 | $30.49 | $12K | Direct | Jan 12, 2022 (2d) |
| Jan 8, 2020 | OPNT | ↓ Sell | 8,785 | $13.47 | $118K | Direct | Jan 9, 2020 (1d) |
| Jan 6, 2020 | OPNT | ↓ Sell | 1,215 | $13.96 | $17K | Direct | Jan 6, 2020 (0d) |
| Dec 6, 2019 | OPNT | ↓ Sell | 2,857 | $13.63 | $39K | Direct | Dec 6, 2019 (0d) |
| Dec 3, 2019 | OPNT | ↓ Sell | 7,143 | $14.02 | $100K | Direct | Dec 4, 2019 (1d) |
| Nov 5, 2019 | OPNT | ↓ Sell | 10,000 | $15.05 | $151K | Direct | Nov 5, 2019 (0d) |
| Oct 3, 2019 | OPNT | ↓ Sell | 10,000 | $14.68 | $147K | Direct | Oct 3, 2019 (0d) |
| Sep 4, 2019 | OPNT | ↓ Sell | 10,000 | $14.15 | $142K | Direct | Sep 4, 2019 (0d) |
| Aug 2, 2019 | OPNT | ↓ Sell | 10,000 | $11.60 | $116K | Direct | Aug 2, 2019 (0d) |
| Jul 2, 2019 | OPNT | ↓ Sell | 10,000 | $13.19 | $132K | Direct | Jul 2, 2019 (0d) |
| Jun 4, 2019 | OPNT | ↓ Sell | 10,000 | $11.71 | $117K | Direct | Jun 4, 2019 (0d) |
| May 2, 2019 | OPNT | ↓ Sell | 10,000 | $11.39 | $114K | Direct | May 3, 2019 (1d) |
| Apr 2, 2019 | OPNT | ↓ Sell | 10,000 | $12.66 | $127K | Direct | Apr 3, 2019 (1d) |
| Mar 1, 2019 | OPNT | ↓ Sell | 10,000 | $14.95 | $150K | Direct | Mar 4, 2019 (3d) |
| Feb 4, 2019 | OPNT | ↓ Sell | 10,000 | $15.32 | $153K | Direct | Feb 4, 2019 (0d) |
| Jan 4, 2019 | OPNT | ↓ Sell | 10,000 | $13.76 | $138K | Direct | Jan 4, 2019 (0d) |
| Dec 6, 2018 | OPNT | ↓ Sell | 4,321 | $16.06 | $69K | Direct | Dec 6, 2018 (0d) |
| Nov 6, 2018 | OPNT | ↓ Sell10b5-1 | 3,217 | $16.81 | $54K | Direct | Nov 8, 2018 (2d) |
| Nov 5, 2018 | OPNT | ↓ Sell | 1,821 | $18.01 | $33K | Direct | Nov 5, 2018 (0d) |
| Oct 4, 2018 | OPNT | ↓ Sell | 4,778 | $18.32 | $88K | Direct | Oct 4, 2018 (0d) |
| Apr 3, 2006 | DOVP | ↓ Sell | 5,000 | $16.05 | $80K | Direct | Apr 5, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Phil Skolnick's insider trades
Phil Skolnick is Chief Scientific Officer at Opiant Pharmaceuticals (OPNT). Since Apr 3, 2006, Phil has reported no open-market purchases and 26 sales worth $2.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (2% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (16 filings), grants and awards (11 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.